Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 203
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans
Ibogaine – The Promise, the Protocol, and Protecting the Sacred
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...
“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
March & April 2025 Psychedelic Patent Update: Lykos’ Patent Woes Continue; Filings Provide First Look at Seaport’s 2-Bromo-LSD Program; Delix’s Ergoline Analogues; CaaMTech’s Spinout
Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics...
PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors
Levitee Labs Announces DTC Eligibility Approval
PTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit...
Numinus Completes Acquisition of Neurology Centre of Toronto
Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial...
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
ATMA Journey Centers Offer Regulated Health Care Professionals a Means to...
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey...
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data
1
...
202
203
204
...
286
Page 203 of 286
